Medication info
Elzero Tablet 4 mg (Pitavastatin Calcium)

Elzero Tablet 4 mg (Pitavastatin Calcium)

Prescription medicationTablet경구
Ingredient · strength
Pitavastatin Calcium›4mg / 1 tablet
Manufacturer / importer
(주)보령
Appearance
Yellow round film-coated tablet with a score line
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202008230 · Approved 2020.11.26 · Insurance code 641908230

Summary

Main use
Improvement of hypercholesterolemia and dyslipidemia
Who takes it
Adults
Adult dose
For adults, the initial dose of Pitavastatin Calcium is 1-2 mg once daily. If the LDL-cholesterol lowering effect is insufficient, the dose may be increased up to a maximum of 4 mg daily. Adjustments should be made appropriately with a 4-week interval or longer.

Ingredients

Manufacturer
(주)보령

Efficacy & effects

Improvement of hypercholesterolemia and dyslipidemia

View approved original text

This medication helps improve the blood lipid levels of patients with primary hypercholesterolemia and mixed dyslipidemia. It particularly lowers total cholesterol, LDL cholesterol, apo-B protein, and triglycerides while increasing good cholesterol, HDL cholesterol. It plays a significant role in managing lipid imbalance in conjunction with dietary therapy. This helps to reduce the risk of cardiovascular diseases and maintain healthy blood vessels. Therefore, this medication serves as an effective adjunct in the treatment of dyslipidemia.

How to take

Adult dose

For adults, the initial dose of Pitavastatin Calcium is 1-2 mg once daily. If the LDL-cholesterol lowering effect is insufficient, the dose may be increased up to a maximum of 4 mg daily. Adjustments should be made appropriately with a 4-week interval or longer.

Precautions

This drug should not be used in certain patients. For example, it should not be administered to patients who are allergic to any component of this drug, those with severely impaired liver function, pregnant women or those who may become pregnant, nursing women, and children. Additionally, patients with renal function abnormalities or a history of liver disease should exercise caution when using this drug. Specifically, the risk of muscle-related problems may increase when taken with certain other medications, so it is advisable to avoid combination therapy. While taking this drug, side effects such as muscle pain, weakness, skin rash, digestive discomfort, and liver function abnormalities may occur, and any abnormal symptoms should be consulted with medical personnel immediately. Regular liver function tests should be conducted, and the medication may need to be discontinued if liver levels are elevated. Treatment should be discontinued if muscle-related symptoms or abnormalities are found in blood tests. As this drug is used for the treatment of hypercholesterolemia, it is important to check blood lipid levels before administration and to follow a diet and exercise regimen. Elderly patients or those with specific conditions may be at higher risk for side effects, requiring careful dose adjustment and close observation. Pregnant or nursing women should not take this medication, and it should also be avoided if pregnancy is planned. This drug may interact with other medications, so it is essential to inform medical personnel about any ongoing prescriptions. Finally, this drug should be swallowed whole without splitting, and it must be stored out of reach of children.

Side effects and when to seek care immediately

Serious side effects

Hives, severe swelling (edema), chest tightness, breathing difficulties, cold sweat, pallor, severe rash with high fever, blisters, peeling skin, pain in mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attack, cough with fever accompanied respiratory abnormalities, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urination

Mild side effects

  • Abdominal pain
  • rash
  • fatigue
  • numbness
  • itching
  • stiffness
  • drowsiness
  • insomnia
  • headache
  • heavy head
Show 25 more
  • dizziness
  • dry mouth
  • indigestion
  • abdominal bloating
  • constipation
  • stomatitis
  • vomiting
  • loss of appetite
  • glossitis
  • nausea
  • gastrointestinal discomfort
  • diarrhea
  • thrombocytopenia
  • granulocytopenia
  • leukopenia
  • eosinophilia
  • leukocytosis
  • increased globulin
  • positive Coombs test
  • anemia
  • increased urination
  • elevated BUN
  • elevated serum creatinine
  • decreased aldosterone
  • aldol

Not everyone experiences these, and they can vary from person to person.

Storage

This drug may be sensitive to light, so it should be stored in a container that protects it from light. Additionally, the drug should be kept at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Yellow round film-coated tablet with a score line

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.